Ron Gill, Ph.D.



Ron is the CTO of Xsensio, where he is in charge of expanding the company’s proprietary Lab-on-Skin™ sensing platform to new applications. He earned his Ph.D. in Chemistry from the Hebrew University in Jerusalem. He then spent two years as a post-doc in the Medical Diagnostics Group at Philips Research Labs in Eindhoven, the Netherlands. After several years as an Assistant Professor at the University of Twente in the Netherlands, he joined the Dutch start-up Biovolt BV, where he was managing the technology development of diagnostics assays for metabolic syndrome-related health issues.